Skip to main content
Erschienen in: Annals of Hematology 6/2007

01.06.2007 | Original Article

Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders

verfasst von: P. K. Gupta, V. D. Charan, R. Saxena

Erschienen in: Annals of Hematology | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Platelet function disorders (PFD) and Von Willebrand disease (VWD) are among the uncommon causes of bleeding in haematological practice. The inherited variety of PFD includes defects in platelet adhesion, aggregation, secretion and platelet procoagulant activities. VWD is classified into three major categories—type 1 and 3 (quantitative deficiency) and type 2 VWD (qualitative defect). In the present study, the profile and prevalence of inherited PFD and VWD in Indians are described. Two thousand eight hundred patients with history of muco-cutaneous bleeding and other bleeding disorders were investigated. The tests performed included platelet count, bleeding time, PT, APTT, F VIII assay, platelet factor 3 (PF3) availability, platelet aggregation studies, VWF:Ag, VWF:RCo and multimeric analysis. Out of 2,800 patients investigated, a total of 872 (31.1%) were characterized to have either inherited coagulation defects (64.2%) or inherited platelet function disorders (35.8%). Of these 872patients, 312 (35.8%) cases were characterized to have inherited PFD and 94 (16.8%) patients as VWD. Among 312 inherited PFD patients, isolated PF3 availability defect (48.1%) was most common, followed by unclassified PFD (37.2%). Among 94 VWD patients, type 2 VWD was most common (44.7%), followed by type 3 VWD (34.5%) and type 1 VWD (21.3%), respectively. Bleeding manifestations included easy bruising (46%), undue prolonged bleeding from trivial injuries (50% in PFD and type 1 and type 2 VWD and 100% in type 3 VWD), menorrhagia (31%), gum bleeds (22%), epistaxis (55%), haematuria (6%), GI bleeds (11%) and rarely, haematomas and haemarthoses (4%). In conclusion, VWD and inherited platelet function disorders are not uncommon among Indian population presenting with bleeding disorders.
Literatur
1.
Zurück zum Zitat Ramasamy L (2004) Inherited bleeding disorders: disorders of platelet adhesion and aggregation. Crit Rev Oncol Hematol 49(1):1–35PubMed Ramasamy L (2004) Inherited bleeding disorders: disorders of platelet adhesion and aggregation. Crit Rev Oncol Hematol 49(1):1–35PubMed
2.
Zurück zum Zitat Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR et al (2000) von Willebrand disease in a pediatric based population—comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding asay. Thromb Haemost 84:401–409PubMed Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR et al (2000) von Willebrand disease in a pediatric based population—comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding asay. Thromb Haemost 84:401–409PubMed
4.
Zurück zum Zitat Coller BS, Seligsohn U, Peretz H, Newman PJ (1994) Glanzmann thrombasthenia: new insights from an historical perspective. Semin Hematol 31:301–311PubMed Coller BS, Seligsohn U, Peretz H, Newman PJ (1994) Glanzmann thrombasthenia: new insights from an historical perspective. Semin Hematol 31:301–311PubMed
5.
Zurück zum Zitat Rao AK, Gabbeta J (2002) Congenital disorders of platelet signal transduction. Arterioscler Thromb Vasc Biol 20:285–289 Rao AK, Gabbeta J (2002) Congenital disorders of platelet signal transduction. Arterioscler Thromb Vasc Biol 20:285–289
6.
Zurück zum Zitat Sadler JE (1994) A revised classification of von Willebrand disease. Thromb Haemost 71:520–525PubMed Sadler JE (1994) A revised classification of von Willebrand disease. Thromb Haemost 71:520–525PubMed
7.
Zurück zum Zitat Saraya AK, Pati HD (1994) Platelet factor 3 deficiency: an associated defect in functional platelet disorders of acquired and congenital origin. Hematol Rev 9:21–26 Saraya AK, Pati HD (1994) Platelet factor 3 deficiency: an associated defect in functional platelet disorders of acquired and congenital origin. Hematol Rev 9:21–26
8.
Zurück zum Zitat Lewis SM, Barn BJ, Bater I (2001) Dacie and Lewis practical haematology, 9th edn. Churchill Livingstone, London, UK Lewis SM, Barn BJ, Bater I (2001) Dacie and Lewis practical haematology, 9th edn. Churchill Livingstone, London, UK
9.
Zurück zum Zitat Hardisty RM, Hutton RA (1966) Platelet aggregation and the availability of platelet factor 3. Br J Haematol 12:764–766PubMed Hardisty RM, Hutton RA (1966) Platelet aggregation and the availability of platelet factor 3. Br J Haematol 12:764–766PubMed
10.
Zurück zum Zitat Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J (1973) Quantitative assay of a plasma factor deficient in von Willebrand’s disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 52:2798–2816 Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J (1973) Quantitative assay of a plasma factor deficient in von Willebrand’s disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 52:2798–2816
11.
Zurück zum Zitat Ruggeri ZM, Zimmermann TS (1981) The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140–1143PubMed Ruggeri ZM, Zimmermann TS (1981) The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140–1143PubMed
12.
Zurück zum Zitat Enayat MS, Hill FGH (1983) Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 36:915–919PubMed Enayat MS, Hill FGH (1983) Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 36:915–919PubMed
13.
Zurück zum Zitat Gupta PK, Ahmed R, Kannan M, Chatterjee T, Choudhry VP, Saxena R (2004) Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease. Ann Hematol 83:489–490PubMedCrossRef Gupta PK, Ahmed R, Kannan M, Chatterjee T, Choudhry VP, Saxena R (2004) Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease. Ann Hematol 83:489–490PubMedCrossRef
14.
Zurück zum Zitat Nurden AT, Nurden P (2001) Inherited defects of platelet function. Rev Clin Exp Hematol 9:314–344CrossRef Nurden AT, Nurden P (2001) Inherited defects of platelet function. Rev Clin Exp Hematol 9:314–344CrossRef
15.
Zurück zum Zitat Lusher JM (1999) Systemic causes of excessive uterine bleeding. Semin Hematol 36(Suppl 4):10–20PubMed Lusher JM (1999) Systemic causes of excessive uterine bleeding. Semin Hematol 36(Suppl 4):10–20PubMed
16.
Zurück zum Zitat Tuddenham EGD (1989) Von Willebrand factor and its disorders: an overview of recent molecular studies. Blood Rev 3:251–262PubMedCrossRef Tuddenham EGD (1989) Von Willebrand factor and its disorders: an overview of recent molecular studies. Blood Rev 3:251–262PubMedCrossRef
17.
Zurück zum Zitat Lenk H, Nilsson IM, Holmberg L, Weissbach G (1988) Frequency of different types of von Willebrand’s disease in the GDR. Acta Med Scand 224:275–280PubMedCrossRef Lenk H, Nilsson IM, Holmberg L, Weissbach G (1988) Frequency of different types of von Willebrand’s disease in the GDR. Acta Med Scand 224:275–280PubMedCrossRef
18.
Zurück zum Zitat Kasper Carol K (2003) The Haemophilia Bulletin August 4th issue. Orthopaedic Hospital 24003 Flower St., Los Angles, CA-90007 Kasper Carol K (2003) The Haemophilia Bulletin August 4th issue. Orthopaedic Hospital 24003 Flower St., Los Angles, CA-90007
19.
Zurück zum Zitat Nitu-Whalley IC, Riddell A, Lee CA, Pasi KJ, Owens D, Enayat MS, Perkins SJ, Jenkins PV (2000) Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modeling. Thromb Haemost 84:998–1004PubMed Nitu-Whalley IC, Riddell A, Lee CA, Pasi KJ, Owens D, Enayat MS, Perkins SJ, Jenkins PV (2000) Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modeling. Thromb Haemost 84:998–1004PubMed
20.
Zurück zum Zitat Gupta PK, Ahmed RPH, Sazawal S et al (2005) Relatively high frequency of VWD types 3 and 2 in a Cohort of Indian patients: the role of multimeric analysis. J Thromb Haemost 3(6):1321–1323PubMedCrossRef Gupta PK, Ahmed RPH, Sazawal S et al (2005) Relatively high frequency of VWD types 3 and 2 in a Cohort of Indian patients: the role of multimeric analysis. J Thromb Haemost 3(6):1321–1323PubMedCrossRef
Metadaten
Titel
Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders
verfasst von
P. K. Gupta
V. D. Charan
R. Saxena
Publikationsdatum
01.06.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 6/2007
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0244-8

Weitere Artikel der Ausgabe 6/2007

Annals of Hematology 6/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.